WO2002044318A1 - Improved cell carrier grids - Google Patents
Improved cell carrier grids Download PDFInfo
- Publication number
- WO2002044318A1 WO2002044318A1 PCT/US2001/042844 US0142844W WO0244318A1 WO 2002044318 A1 WO2002044318 A1 WO 2002044318A1 US 0142844 W US0142844 W US 0142844W WO 0244318 A1 WO0244318 A1 WO 0244318A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- holes
- cell
- grid
- cell carrier
- cross
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/26—Inoculator or sampler
- C12M1/32—Inoculator or sampler multiple field or continuous type
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5025—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures for parallel transport of multiple samples
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5025—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures for parallel transport of multiple samples
- B01L3/50255—Multi-well filtration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L9/00—Supporting devices; Holding devices
- B01L9/56—Means for indicating position of a recipient or sample in an array
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/12—Well or multiwell plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0829—Multi-well plates; Microtitration plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
- B01L2400/049—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics vacuum
Definitions
- a sample may contain a physiologically mixed population of cells, only a portion of which is to be analyzed.
- Machines such as a fluorescence activated cell sorter (FACS) were designed, in part, to overcome this problem.
- FACS fluorescence activated cell sorter
- a FACS machine cannot reassay individual cells after sorting. This limitation precludes both kinetic studies of individual cells and recovery of individual cells after assay based upon assay results.
- U.S. Pat. No. 4,729,949 teaches methods and apparatus for performing analyses on individual living cells. According to the teachings of this patent, individual cells are forced into holes in a grid so that each of the cells may be individually assayed and re-assayed. The teachings of this patent do not provide means for assuring that all cells are held in a single focal plane during their residence in the grid and subsequent assay. As a result, practice of the teachings of this patent introduces inaccuracy into the measurements.
- U.S. Pat. No. 5,310,674 is similar except that it teaches an ordered array of holes of two different sizes so that sorting of cells by size into two subpopulations is theoretically feasible. Teachings of this patent do not explain why a large cell will not be retained in a small hole when suction is applied therethrough.
- U.S. Pat. No.5, 272,081 teaches identification and subculture of a selected subgroup of cells residing in a grid of the type taught in U.S. Pat. No. 4,729,949. Therefore, the same inherent drawbacks are present in the teachings of this patent.
- U.S. Pat. No. 5,506,141 is similar to U.S. Pat. No.
- T-cells in order to allow for the labeling, identification and separation of specific T cells.
- a cell carrier grid capable of containing and retaining individual living cells in an array of predefined discrete locations.
- the cell carrier grid comprises (a) a body that defines a first and a second outer surface, the body having an ordered array of holes therethrough, each of the holes communicating between the first outer surface and the second outer surface; (b) an organizational plan, the plan being applied to the positioning of the holes on the body such that a position of each of the holes is identifiable so that the holes form the array of predefined discrete locations.
- Each of the holes is sized to contain at least a portion of an individual living cell therewithin, in that each hole has: (i) a first cross section at the first outer surface of such dimensions that at least a portion of the individual living cell can pass through the first cross section without suffering substantial damage; (ii) a second cross section at a level intermediate between the first and the second outer surfaces of such dimensions that the individual living cell cannot pass through the second cross section; (iii) a height between the first outer surface and the level of the second cross section such that at least a portion of the individual living cell is containable within the hole, and the individual cell is retained therein.
- the body is designed and constructed such that the individual cells contained within the holes reside substantially in a single focal plane during analysis and accuracy of data collected from the individual cells within the holes is increased because the cells reside substantially in a single focal plane.
- a cell carrier grid capable of containing and retaining individual living cells in an array of predefined discrete locations
- the cell carrier grid comprising; (a) a body that defines a first and a second outer surface, the body having an ordered array of holes therethrough, each of the holes communicating between the first outer surface and the second outer surface; (b) an organizational plan, the plan being applied to the positioning of the holes on the body such that a position of each of the holes is identifiable so that the holes form the array of predefined discrete locations; and (c) wherein each of the holes is sized to contain at least a portion of an individual living cell therewithin, in that each hole has (i) a first cross section at the first outer surface of such dimensions that at least a portion of the individual living cell can pass through the first cross section without suffering substantial damage; (ii) a second cross section at a level intermediate between the first and the second outer surfaces said second cross section being no greater in size than said first cross section; and (iii) a height between the
- a cell carrier grid capable of containing and retaining individual living cells in an array of predefined discrete locations
- the cell carrier grid comprising; (a) a body that defines a first and a second outer surface, the body having an ordered array of holes therethrough, each of the holes communicating between the first outer surface and the second outer surface; (b) an organizational plan, the plan being applied to the positioning of the holes on the body such that a position of each of the holes is identifiable so that the holes form the array of predefined discrete locations and (c) wherein each of the holes is sized to contain at least a portion of an individual living cell therewithin, in that each hole has (i) a first cross section at the first outer surface of such dimensions that at least a portion of the individual living cell can pass through the first cross section without suffering substantial damage; (ii) a second cross section at a level intermediate between the first and the second outer surfaces said second cross section being no greater in size than said first cross section; and (iii) a height between the
- the body is inherently rigid, such that the individual cells contained within the holes reside substantially in a single focal plane during analysis.
- the cell carrier grid of claim 1 wherein the body is supported by at least one support, such that the individual cells contained within the holes reside substantially in a single focal plane during analysis.
- the cell carrier grid further includes a holder designed and constructed to: (i) facilitate manipulation of the cell carrier grid; (ii) allow application of suction through the holes in the grid such that cells in suspension applied to the first outer surface of the grid tend to move towards and into the holes; and (iii) permit application and removal of solutions to cells residing in the holes.
- the biologically active material includes at least one material selected from the group consisting of a protein, a carbohydrate, a nucleic acid, and a lipid.
- the protein is selected from the group consisting of an antibody, an antigen, biotin, avidin, streptavidin, an enzyme, a ligand, a receptor, a mitogen, a haptene, a multimeric MHC-antigen complex and a lectin.
- the nucleic acid is selected from the group consisting of DNA, RNA and derivatives thereof.
- the lipid is selected from the group consisting of Lysophosphatydilcholine (polar phospholipid) and OxLDL
- the biologically active material is used to coat the body at a location selected from the group consisting of within the holes and adjacent to the holes.
- the biologically active material comprises at least two separate biologically active materials, each of the at least two materials applied to a portion of the holes comprising the array of predefined discrete locations.
- At least 20% of the individual living cell contained within a hole extends beyond a plane defined by the first outer surface to render the cell recoverable by a recovery device.
- the present invention successfully addresses the shortcomings of the presently known configurations by providing cell carrier grids which are coated with biologically active materials and cell carrier grids designed and constructed to hold cells in a single focal plane for analysis.
- the present invention further relates to cell carrier grids which allow recovery of individual cells based upon the results of analyses conducted thereupon.
- FIG. 1 is a perspective view of a cell carrier grid according to the present invention
- FIG. 2 is a is a cross sectional view of a cell carrier grid of the present invention showing alternate embodiments of holes therein;
- FIGs. 3a and 3b show two possible arrangements for an array of holes in a cell carrier grid according to the present invention
- FIGs. 3c and 3d show two possible ways in which different holes might be coated with different biologically active materials while some holes remain uncoated;
- the present invention is of improved cell carrier grids which can be coated with biologically active materials, can be designed and constructed to hold cells in a single focal plane for analysis and which allow recovery of individual cells based upon the results of analyses conducted thereupon.
- the present invention can be used to used to regulate a biological function in cells before or during assay, to increase the accuracy of assays performed on cells contained in the cell carrier grid and to allow recovery of individual cells based upon the results of analyses conducted thereupon.
- FIG. 1 shows a cell carrier grid 20 capable of containing and retaining individual living cells in an array 24 of predefined discrete locations 26.
- Grid 20 may include, for example, a 100 X 100 2-dimensional array of holes 26.
- each hole 26 has a first cross section 32 at first outer surface 28 of such dimensions that at least a portion of the individual living cell can pass through first cross section 32 without suffering substantial damage.
- Each of holes 26 also has a second cross section 34 at a level intermediate between the first and the second outer surfaces (28 and 30). In some cases this second cross section 34 is of such dimensions that the individual living cell cannot pass therethrough. In other cases, second cross section 34 is similar to first cross section 32.
- a height 36 is defined between first outer surface 28 and the level of second cross section 34 such that at least a portion of the individual living cell is containable within the hole, and the individual cell is retained therein.
- body 22 is designed and constructed such that the individual cells at least partially contained within holes 26 reside substantially in a single focal plane during analysis. This is achieved by imparting addition physical strength to grid 20, which also serves to prevent damage to grid 20 during use. As a result, accuracy of data collected from the individual cells within holes 26 is increased relative to prior art teachings.
- Holding of cells in a single focal plane may be achieved, for example, by constructing body 22 of inherently rigid materials.
- a Grid diagram at 1,000:1 is drawn on a computer.
- This diagram is a map of array 24 of holes 26 of grid 20.
- the diagram is then "inverted” and reduced by means of a computer program or by photography. This produces a reduced size negative of the grid.
- a further downscaling is achieved by projecting the negative through a microscope in the opposite direction, thereby receiving the desired picture on the side of the objective. This process produces a picture in which holes 26 are in the desired size (typically several microns).
- This picture of the grid is projected through the objective lens onto a thin metal paper (e.g.
- copper paper of 0.5-mm thickness which is covered photo-emulsion.
- the emulsion changes its structure upon exposure to light. Typically several hundred grids are projected on a single sheet.
- the metal paper is then sequentially immersed in developer, fixer and a wash solution. This produces metal paper with fixed pictures of grids.
- the developing chemicals that are used, which stay on the metal paper, are non-conductive.
- the metal paper is then electroplated with a metal such as Nickel, Gold or Silver.
- the areas that are covered with the developmental chemicals are not coated in this process since they do not conduct electricity. This produces a metal picture of the projected. This process is repeated cyclically until holes 26 have the desired height 36 as detailed hereinbelow.
- Suitable lipids include, but are not limited to Lysophosphatydilcholine (polar phospholipid) and OxLDL. It is known that preincubation with OxLDL can alter fluorescence of cells stained with FDA (N. Zurgil et al. (1999)Clin. Cardiol 22:5260-532). Coating of cell carrier grids is therefore an improvement upon this technique for assaying aterosclerosis which is currently being developed. Similarly Lysophosphatydilcholine has been demonstrated to activate lymphocytes (N Zurgil, unpublished results).
- Coating of cell carrier grids with this material is a significant improvement upon this technique for assaying arteriosclerosis because it brings individual cells into a micro-environment with a higher local concentration of reagent than that achievable using prior art teachings.
- supply of coated grids makes the assay simpler to perform by eliminating the need for incubation of cells with the material employed in the coating. This, in tern, reduces the level of skill required of a user of grid 20.
- biologically active material 58 includes at least two separate biologically active materials, each of the at least two materials applied to a portion of holes 26 in array 24 of predefined discrete locations.
- Figures 3c and 3d show two possible arrangements of biologically active materials 1, 2, and 3 in holes 26.
- each biologically active material may include a combination of materials.
- 3 may represent a combination of 1 and 2.
- Such an embodiment allows rapid and easy discovery of synergy between different coating materials.
- 0 is used to represent holes with no biologically active material.
- Such holes would typically serve to provide a baseline or negative control reading for an assay. This allows concurrent assay of more than one biologically active material on a single grid 20, something which is infeasible using prior art methods.
- body 22 is designed and constructed such that the individual cells contained witliin holes 26 are recoverable by a recovery device. This may be achieved, for example, by making height 36 less than the average radius of cells contained in holes 26. According to preferred embodiments of the invention at least 20%, more preferably at least 40%, most preferably at least 50% of the individual living cell contained within a hole extends beyond a plane defined by first outer surface 28 of body 22 to render the cell recoverable by a recovery device. Table 1 shows calculated well depths for cell types of research interest.
- Table 1 Well depths required for various percentages of selected cell types to protrude from a well.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Clinical Laboratory Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002226882A AU2002226882A1 (en) | 2000-11-28 | 2001-10-30 | Improved cell carrier grids |
EP01995835A EP1337622A4 (en) | 2000-11-28 | 2001-10-30 | Improved cell carrier grids |
CA002427990A CA2427990C (en) | 2000-11-28 | 2001-10-30 | Improved cell carrier grids |
JP2002546667A JP3940361B2 (en) | 2000-11-28 | 2001-10-30 | Improved cell carrier grid |
KR1020037007193A KR100873228B1 (en) | 2000-11-28 | 2001-10-30 | Improved cell carrier grids |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25313400P | 2000-11-28 | 2000-11-28 | |
US60/253,134 | 2000-11-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002044318A1 true WO2002044318A1 (en) | 2002-06-06 |
Family
ID=22959012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/042844 WO2002044318A1 (en) | 2000-11-28 | 2001-10-30 | Improved cell carrier grids |
Country Status (8)
Country | Link |
---|---|
US (1) | US6495340B2 (en) |
EP (1) | EP1337622A4 (en) |
JP (1) | JP3940361B2 (en) |
KR (1) | KR100873228B1 (en) |
CN (1) | CN1271197C (en) |
AU (1) | AU2002226882A1 (en) |
CA (1) | CA2427990C (en) |
WO (1) | WO2002044318A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007102078A1 (en) * | 2006-03-08 | 2007-09-13 | Cell Kinetics Ltd. | Hole-type cell carriers that promote cell adhesion and/or viability |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8585971B2 (en) | 2005-04-05 | 2013-11-19 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US8895298B2 (en) | 2002-09-27 | 2014-11-25 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US10591391B2 (en) | 2006-06-14 | 2020-03-17 | Verinata Health, Inc. | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US10704090B2 (en) | 2006-06-14 | 2020-07-07 | Verinata Health, Inc. | Fetal aneuploidy detection by sequencing |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL136232A0 (en) * | 2000-05-18 | 2001-05-20 | Bar Ilan University Res Author | Measurements of enzymatic activity in a single, individual cell in population |
US6495340B2 (en) * | 2000-11-28 | 2002-12-17 | Medis El Ltd. | Cell carrier grids |
US20020106715A1 (en) * | 2001-02-02 | 2002-08-08 | Medisel Ltd | System and method for collecting data from individual cells |
EP1438753B1 (en) * | 2001-10-11 | 2010-04-07 | Koninklijke Philips Electronics N.V. | Thin film transistor device and method of manufacturing same |
US20050014201A1 (en) * | 2001-10-25 | 2005-01-20 | Mordechai Deuthsch | Interactive transparent individual cells biochip processor |
IL154677A0 (en) * | 2003-02-27 | 2003-09-17 | Univ Bar Ilan | A method and apparatus for manipulating an individual cell |
US20040248205A1 (en) * | 2003-04-16 | 2004-12-09 | Stern Lawrence J. | Major histocompatibility complex (MHC)-peptide arrays |
US7888110B2 (en) | 2003-06-26 | 2011-02-15 | Seng Enterprises Ltd. | Pico liter well holding device and method of making the same |
US8597597B2 (en) | 2003-06-26 | 2013-12-03 | Seng Enterprises Ltd. | Picoliter well holding device and method of making the same |
US9200245B2 (en) | 2003-06-26 | 2015-12-01 | Seng Enterprises Ltd. | Multiwell plate |
US20050064524A1 (en) * | 2003-08-11 | 2005-03-24 | Mordechai Deutsch | Population of cells utilizable for substance detection and methods and devices using same |
US7403647B2 (en) * | 2004-09-13 | 2008-07-22 | Seng Enterprises Ltd. | Method for identifying an image of a well in an image of a well-bearing component |
US20060057435A1 (en) * | 2004-09-15 | 2006-03-16 | Medis Technologies Ltd | Method and apparatus for preventing fuel decomposition in a direct liquid fuel cell |
WO2006080000A1 (en) | 2005-01-25 | 2006-08-03 | Seng Enterprises Ltd. | Device for the studying individual cells |
JP4579745B2 (en) * | 2005-03-31 | 2010-11-10 | 富士通株式会社 | Cell capture device |
DE102005034043B4 (en) * | 2005-07-18 | 2019-12-12 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Mixture containing L-carnitine and trehalulose and product containing the mixture |
JP4659553B2 (en) * | 2005-08-05 | 2011-03-30 | 富士通株式会社 | Automatic microinjection device and cell capture plate |
US8288120B2 (en) | 2005-11-03 | 2012-10-16 | Seng Enterprises Ltd. | Method for studying floating, living cells |
WO2007122602A1 (en) * | 2006-04-26 | 2007-11-01 | Seng Enterprises Ltd. | A method and system for measuring membrane potential based on fluorescence polarization |
WO2008032323A2 (en) * | 2006-09-11 | 2008-03-20 | Seng Enterprises Ltd. | Method of determining lymph node metastasis |
US9145540B1 (en) | 2007-11-15 | 2015-09-29 | Seng Enterprises Ltd. | Device for the study of living cells |
EP2237887A2 (en) * | 2007-12-26 | 2010-10-13 | Seng Enterprises Ltd. | Device for the study of living cells |
USD802157S1 (en) * | 2014-03-02 | 2017-11-07 | Pluristem Ltd. | Carrier for cell culture |
KR102095466B1 (en) | 2018-08-29 | 2020-03-31 | 정진우 | Ice storage tank of cooling thermal energy storagesystem |
CN209331001U (en) * | 2018-11-09 | 2019-09-03 | 彭秋平 | Freezing carries bar |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4729949A (en) * | 1982-05-10 | 1988-03-08 | Bar-Ilan University | System and methods for cell selection |
US4772540A (en) * | 1985-08-30 | 1988-09-20 | Bar Ilan University | Manufacture of microsieves and the resulting microsieves |
US5272081A (en) * | 1982-05-10 | 1993-12-21 | Bar-Ilan University | System and methods for cell selection |
US5310674A (en) * | 1982-05-10 | 1994-05-10 | Bar-Ilan University | Apertured cell carrier |
US6103479A (en) * | 1996-05-30 | 2000-08-15 | Cellomics, Inc. | Miniaturized cell array methods and apparatus for cell-based screening |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4877659A (en) * | 1988-08-02 | 1989-10-31 | Inti Corporation | Multiwell assay/culture strip |
US5183744A (en) * | 1988-10-26 | 1993-02-02 | Hitachi, Ltd. | Cell handling method for cell fusion processor |
US6022700A (en) * | 1998-03-12 | 2000-02-08 | Intelligent Imaging Innovations, Inc. | High throughput biological sample preparation device and methods for use thereof |
US6495340B2 (en) * | 2000-11-28 | 2002-12-17 | Medis El Ltd. | Cell carrier grids |
US20020106715A1 (en) * | 2001-02-02 | 2002-08-08 | Medisel Ltd | System and method for collecting data from individual cells |
-
2001
- 2001-06-22 US US09/886,205 patent/US6495340B2/en not_active Expired - Fee Related
- 2001-10-30 AU AU2002226882A patent/AU2002226882A1/en not_active Abandoned
- 2001-10-30 KR KR1020037007193A patent/KR100873228B1/en not_active IP Right Cessation
- 2001-10-30 EP EP01995835A patent/EP1337622A4/en not_active Withdrawn
- 2001-10-30 CN CNB018212778A patent/CN1271197C/en not_active Expired - Fee Related
- 2001-10-30 CA CA002427990A patent/CA2427990C/en not_active Expired - Fee Related
- 2001-10-30 JP JP2002546667A patent/JP3940361B2/en not_active Expired - Fee Related
- 2001-10-30 WO PCT/US2001/042844 patent/WO2002044318A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4729949A (en) * | 1982-05-10 | 1988-03-08 | Bar-Ilan University | System and methods for cell selection |
US5272081A (en) * | 1982-05-10 | 1993-12-21 | Bar-Ilan University | System and methods for cell selection |
US5310674A (en) * | 1982-05-10 | 1994-05-10 | Bar-Ilan University | Apertured cell carrier |
US5506141A (en) * | 1982-05-10 | 1996-04-09 | Bar-Ilan University | Apertured cell carrier |
US4772540A (en) * | 1985-08-30 | 1988-09-20 | Bar Ilan University | Manufacture of microsieves and the resulting microsieves |
US6103479A (en) * | 1996-05-30 | 2000-08-15 | Cellomics, Inc. | Miniaturized cell array methods and apparatus for cell-based screening |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8895298B2 (en) | 2002-09-27 | 2014-11-25 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US11052392B2 (en) | 2002-09-27 | 2021-07-06 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US10081014B2 (en) | 2002-09-27 | 2018-09-25 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US8986966B2 (en) | 2002-09-27 | 2015-03-24 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US8585971B2 (en) | 2005-04-05 | 2013-11-19 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US9174222B2 (en) | 2005-04-05 | 2015-11-03 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US9956562B2 (en) | 2005-04-05 | 2018-05-01 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US10786817B2 (en) | 2005-04-05 | 2020-09-29 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
WO2007102078A1 (en) * | 2006-03-08 | 2007-09-13 | Cell Kinetics Ltd. | Hole-type cell carriers that promote cell adhesion and/or viability |
US10704090B2 (en) | 2006-06-14 | 2020-07-07 | Verinata Health, Inc. | Fetal aneuploidy detection by sequencing |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US9017942B2 (en) | 2006-06-14 | 2015-04-28 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US11674176B2 (en) | 2006-06-14 | 2023-06-13 | Verinata Health, Inc | Fetal aneuploidy detection by sequencing |
US9273355B2 (en) | 2006-06-14 | 2016-03-01 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US9347100B2 (en) | 2006-06-14 | 2016-05-24 | Gpb Scientific, Llc | Rare cell analysis using sample splitting and DNA tags |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US11781187B2 (en) | 2006-06-14 | 2023-10-10 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US10155984B2 (en) | 2006-06-14 | 2018-12-18 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US10591391B2 (en) | 2006-06-14 | 2020-03-17 | Verinata Health, Inc. | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US10669585B2 (en) | 2008-09-20 | 2020-06-02 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9404157B2 (en) | 2008-09-20 | 2016-08-02 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9353414B2 (en) | 2008-09-20 | 2016-05-31 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8296076B2 (en) | 2008-09-20 | 2012-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuoploidy by sequencing |
US8682594B2 (en) | 2008-09-20 | 2014-03-25 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
Also Published As
Publication number | Publication date |
---|---|
EP1337622A4 (en) | 2006-03-01 |
CN1489626A (en) | 2004-04-14 |
JP3940361B2 (en) | 2007-07-04 |
EP1337622A1 (en) | 2003-08-27 |
CA2427990C (en) | 2009-03-17 |
KR20030070041A (en) | 2003-08-27 |
US6495340B2 (en) | 2002-12-17 |
US20020094567A1 (en) | 2002-07-18 |
CA2427990A1 (en) | 2002-06-06 |
AU2002226882A1 (en) | 2002-06-11 |
KR100873228B1 (en) | 2008-12-10 |
JP2004514442A (en) | 2004-05-20 |
CN1271197C (en) | 2006-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6495340B2 (en) | Cell carrier grids | |
US5779907A (en) | Magnetic microplate separator | |
US4895650A (en) | Magnetic separation rack for diagnostic assays | |
US5188968A (en) | Method and reaction kit for agglutination detection | |
EP1428027B1 (en) | Dielectrophoretic method and apparatus for high throughput screening | |
US7361500B2 (en) | Apparatus and method for electrically contacting biological cells suspended in a liquid | |
US7374906B2 (en) | Biological assays using gradients formed in microfluidic systems | |
US7258837B2 (en) | Microfluidic device and surface decoration process for solid phase affinity binding assays | |
US20190301980A1 (en) | Automated tissue section capture, indexing and storage system and methods | |
US20070105089A1 (en) | Interactive transparent individual cells biochip processor | |
US7226537B2 (en) | Method, device and apparatus for the wet separation of magnetic microparticles | |
WO2000073777A1 (en) | Array cytometry | |
CA2532414A1 (en) | Sensitive and rapid biodetection | |
EP1578194A2 (en) | Biological assays using gradients formed in microfluidic systems | |
EP0435245B1 (en) | Reaction kit | |
US20190271707A1 (en) | Method and Apparatus Employing Magnetic Beads for Ligand Binding Assays of Biological Samples | |
JPH09508462A (en) | Automated analysis with comb-like support | |
WO2022082025A1 (en) | Cellular response analysis method | |
WO2020256695A1 (en) | Method and apparatus employing magnetic beads for ligand binding assays of biological samples | |
AU2012241186A1 (en) | Sensitive and rapid biodetection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2427990 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001995835 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002546667 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020037007193 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018212778 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2001995835 Country of ref document: EP Ref document number: 1020037007193 Country of ref document: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |